CHRS
Coherus BioSciences Inc
Price:  
2.01 
USD
Volume:  
1,287,417.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CHRS EV/EBITDA

-861.7%
Upside

As of 2024-05-23, the EV/EBITDA ratio of Coherus BioSciences Inc (CHRS) is -2.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CHRS's latest enterprise value is 443.03 mil USD. CHRS's TTM EBITDA according to its financial statements is -156.19 mil USD. Dividing these 2 quantities gives us the above CHRS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.9x - 10.1x 10.0x
Forward P/E multiples 6.6x - 12.9x 9.4x
Fair Price (14.17) - (15.85) (15.31)
Upside -804.9% - -888.4% -861.7%
2.01 USD
Stock Price
(15.31) USD
Fair Price

CHRS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-23 -2.84
2024-05-22 -2.91
2024-05-21 -2.89
2024-05-20 -2.89
2024-05-17 -2.92
2024-05-16 -2.95
2024-05-15 -2.96
2024-05-14 -2.89
2024-05-13 -2.89
2024-05-10 -2.76
2024-05-09 -2.92
2024-05-08 -3.00
2024-05-07 -3.01
2024-05-06 -2.99
2024-05-03 -3.03
2024-05-02 -2.95
2024-05-01 -2.87
2024-04-30 -2.80
2024-04-29 -2.88
2024-04-26 -2.86
2024-04-25 -2.78
2024-04-24 -2.84
2024-04-23 -2.96
2024-04-22 -2.96
2024-04-19 -2.88
2024-04-18 -2.83
2024-04-17 -2.94
2024-04-16 -2.94
2024-04-15 -2.97
2024-04-12 -3.00
2024-04-11 -3.13
2024-04-10 -3.16
2024-04-09 -3.17
2024-04-08 -3.20
2024-04-05 -3.14
2024-04-04 -3.07
2024-04-03 -3.11
2024-04-02 -3.09
2024-04-01 -3.12
2024-03-28 -3.11
2024-03-27 -3.13
2024-03-26 -3.05
2024-03-25 -3.03
2024-03-22 -3.07
2024-03-21 -3.20
2024-03-20 -3.18
2024-03-19 -3.16
2024-03-18 -2.99
2024-03-15 -2.99
2024-03-14 -2.95